Assessment of interleukin -10 and interferon-gamma with oral squamous cell carcinoma patients compared with healthy subjects as a prediction for early detection and monitor treatment response
DOI:
https://doi.org/10.32828/mdj.v16i1.1026Keywords:
Oral squamous cell carcinoma (OSCC, Interleukin 10 (IL10), interferon gamma (INF- γ)Abstract
Background: In the worldwide oral squamous cell carcinoma (OSCC) is considered to be one of the most deadly diseases, due to it is late in diagnosis and absence of availability of established reliable biomarkers. The aim of current study was designed to detect cytokines in saliva of patient with oral squamous cell carcinoma and compared their levels with the healthy subjects and evaluate their validity as diagnosis and investigated changes of cytokines level in saliva pre-and post- surgical treatment to provide knowledge for exploring the use of saliva to monitor treatment response.
Material and method: whole unstimulated saliva was collected from each individual (25 OSCC patients Pre- and post- surgical removal of tumor and 25 healthy individuals matching with age and gender as control group. saliva was evaluated both cytokines IL 10 and interferon gamma by ELISA.
Result: IL-10 level is increased significantly in group of OSCC patients compared to healthy subjects (control group). Ten days after surgical removal of tumor, salivary level IL10 was decreased significantly in comparison to its level pre-operation. In OSCC patients salivary level interferon gamma was decreased significantly than its level in healthy subjects, ten days after surgical removal of tumor salivary level interferon gamma was increased significantly in group of OSCC patients in comparison to their level before surgical removal of tumor.
Conclusion: salivary levels of both cytokines IL-10, and interferon gamma could prove to be potential biomarkers of OSCC.
References
- Omar Shebli Museedi, Wasan H. Younis. Oral cancer trends in Iraq from 2000 to 2008. The Saudi Journal for Dental Research. Volume 5, issue 1. January 2014, Pages 41-47.
- Hellen-Bandeira-de-Pontes Santos , Thayana-Karla-Guerra dos Santos , Alexandre-Rolim Paz , Yuri-Wanderley Cavalcanti, Cassiano-Francisco-Weege Nonaka, Gustavo-Pina Godoy, Pollianna-Muniz Alves. Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis. Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21 (2): 151-6.
- Xinhua Wang, Ji Xu, Lijuan Wang, Chao Liu, Huiming Wang. The role of cigarette smoking and alcohol consumption in the differentiation of oral squamous cell carcinoma for the males in China. Journal of cancer research and therapeutic. 2015 Volume: 11 Issue: 1 : 141-145
- McDowell L, Collins M, Kleid S, Rischin D, Corry J. T4 squamous cell carcinoma of the tongue without mandibular involvement: surgery or chemoradiotherapy? Oral Surgery Oral Medicine Oral Pathology Oral Radiology 2014; 117: 163-9.
- Cheng YS, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clinical Transl Medicine. 2014; 3(1):3.
- Castagnola M, et al. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Italy. 2011; 31(6):347–357.
- Slavkin HC. Toward molecularly based diagnostics for the oral cavity. J Am Dent Assoc. 1998; 129:1138–1143.
- Lee YH, Wong DT. Saliva: An emerging biofluid for early detection of diseases. America Dental journal. 2009 Aug; 22(4): 241–248.
- Deborah E Citrin1, Ying J Hitchcock , Eun Joo Chung , Jonathan Frandsen , Mary Ellen Urick1 , William Shield1 and David Gaffney. Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiation Oncology journal. 2012; 7:64.
- Osman TA, Costea DE, Johannessen AC. The use of salivary cytokines as a screening tool for oral squamous cell carcinoma: A review of the literature. J Oral Maxillofacial Pathology. 2012; 16(2):256– 261.
- Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunology Rev (2008) 226(1):205–18.
- Chadban SJ, Tesch GH, Foti R, Lan HY, Atkins RC, Nikolic-Paterson DJ. Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology (1998) 94(1):72–8.
- Guillermo Arango Duque and Albert Descoteaux. Macrophage cytokines: involvement in immunity and infectious diseases. Frontiers in Immunology Journal. 7 october,2014; article 491.
- Zaidi MR, Merlino G. The two faces of interferon γ in cancer. Clinical Cancer Research. 2011.Oct 1:17(19):6118-6124.
- Slattery ML, Lundgreen A, Bondurant KL, Wolff RK. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011; 32(11):1660–70.
- Navazesh, M& Kumar, S.2008.Measuring salivary flow Challenges and opportunities. JADA,139,5,35-40
- Spielmann N, Wong DT. Saliva: diagnostics and therapeutic perspectives. Oral Dis 2011. May; 17(4):345–54.
- Duffy SA1, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, Wolf GT, Teknos TN.. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113(4):750–757.
- St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT.. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(8):929–935.
- Katakura A, Kamiyama I, Takano N, Shibahara T, Muramatsu T, Ishihara K, Takagi R, Shouno T.Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll. 2007;48(4):199–203.
- CH Kim, JS Lee, SO Kang, J Bae, SP Hong.Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol. 2007;43(10):1021–1025.
- Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1348–1355.
- Ship JA, Martel, M.K, Ten Haken, R.K, Marsh, L.H, Wolf, G.T, Esclamado, ... R.E. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: one-year results. J Dent Res. 1997; 76(3):807–813.
- Henson BS, et al. Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment. Oral Oncology journal. 1999; 35(3):234–241.
- Malathi L., Rajesh E., Aravindha Babu N. and Sudha Jimson. Biomedical & Pharmacology Journal. Vol. 9(2), 867-870 (2016).
- Giulio Kleiner, Annalisa Marcuzzi, Valentina Zanin, Lorenzo Monasta, and Giorgio Zauli. Cytokine Levels in the Serum of Healthy Subjects. Mediators of Inflammation journal.2013,6pages.
- Sarris AH1, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas F. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Annual Oncology journal. 1999;10(4):433-40
- Salman Aziz, Syed Shoaib Ahmed, Asad Ali, Faiza Akhter Khan, Gulraiz Zulfiqar, Javed Iqbal, Ayyaz Ali Khan, and Muhammad Shoaib. Salivary Immunosuppressive CytokinesIL-10andIL-13AreSignificantly Elevated in Oral Squamous Cell Carcinoma Patients Cancer Investigation. 2015. 33:318–328.
- Liu Jie, Bao Song, Jia-Lin Wang, Zenga-Jun Li,Wan-Hu Li,and Zhe- Haiwang . Polymorphisms of Interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. 2011, World Journal of Gastroenterol, 17, 1362-7.
- Fujieda SH, Sunaga H, Tsuzuki H, Kang Fan G and Saito H. 1999. IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Letter. 1999. 136, 1-9.
- Laszlo Cervenak, Lucia Morbidelli, Daria Donati, Sandra Donnini, Taku Kambayashi, Julia L. Wilson, Håkan Axelson, Esmeralda Castaños-Velez, Hans- Gustaf Ljunggren, ReneDeWaal Malefyt, HarrisJ. Granger, Marina Ziche and Maria Teresa Bejarano. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by Interleukin-10. Blood journal, (2000). Volume 96, 2568-73.
- Terabe M, Park JM, Berzofsky JA. Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Im- munother 2004;53(2):79–85.
- Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 2006; 16(1):38â-52.
- Costa NL, Valadares MC, Souza PPC, Mendonc¸a EF, Oliveira JC, Silva TA, Batista AC. Tumor-associated macrophages and the pro- file of inflammatory cytokines in oral squamous cell carcinoma. Oral Oncol 2013;49(3):216–223.
- Dunn GP. Old LJ. Schreiber RD. The three cancer immuno- editing. Annul Rev Immunology 2004; 22; 329-60.
- Ha¨rtel C., Adam N., Strunk T., Temming P. , Mu¨ ller- Steinhardt M. , and. Schultz C, “Cytokine responses correlate differentially with age in infancy and early childhood,” Clinical and Experimental Immunology, vol. 142, no. 3, pp. 446–453, 2005.
- Chiou-Feng Lin, Chih-Ming Lin, Kang-Yun Lee, Szu-Yuan Wu, Po-Hao Feng, Kuan-Yuan Chen, Hsiao-Chi Chuang, Chia-Ling Chen, Yu-Chih Wang, Po-Chun Tseng and Tsung-Ting Tsa. Escape from IFN-γ-dependent immunosurveillance in tumorigenesis. Journal of Biomedical Science2017 .24:10
- Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016;16(3):131–44.
- Slattery ML, Lundgreen A, Bondurant KL, Wolff RK. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011;32(11):1660–7.
- Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163–89.
- Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol. 2003; 195(3):346–55.
Downloads
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
